Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up
试验速览
- 阶段
- 早期 1 期
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Total success rate
研究概览
简要总结
The aim of this study is to compare two pulpotomy medicaments in primary molars clinically.A total of 200 primary molars with deep caries were treated with two different pulpotomy medicaments (Mineral Trioxide Aggregate and BiodentineTM) in this study. The inclusion criteria for tooth selection were no clinical and radiographic evidence of pulp pathology. During 36 months of follow-up at 3-month intervals, clinical and radiographic success and failures were recorded.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 7 Years 至 15 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •no clinical and radiographic evidence of pulp pathology,
- •no clinical and radiographic symptoms,
- •no history of spontaneous pain and tenderness,
- •no percussion, swelling or sinus tracts and pathologic mobility.
排除标准
- •any clinical or radiographic evidence of pulp degeneration (spontaneous or nocturnal tooth pain, tenderness to percussion, pathological mobility, internal or external root resorption, swelling or fistula, widened periodontal ligament (PDL)
- •furcal or periapical radiolucency teeth requiring more than 5 minutes to achieve hemostasis during clinical procedure.
- •without permanent successor
研究组 & 干预措施
ProRoot MTA
Dental Materials
干预措施: Biodentine (Drug)
Biodentine
Dental materials
干预措施: Biodentine (Drug)
Biodentine
Dental materials
干预措施: ProRoot (Aggregate) (Drug)
ProRoot MTA
Dental Materials
干预措施: ProRoot (Aggregate) (Drug)
结局指标
主要结局
Total success rate
时间窗: 12 months after pulpotomy treatment
次要结局
- Total success rate(24 months after pulpotomy treatment)
研究者
Mine Koruyucu
Principal Investigator
Istanbul University